Personalized Digital Support to Improve Quality of Life for Adults with Multiple Myeloma Using an Online Platform

What this Trial Is About

Researchers are investigating how a personalized web-based digital platform can improve the quality of life for adults with multiple myeloma by monitoring patient-reported outcomes PROs. The study aims to compare the effectiveness of personalized educational and supportive content delivered through this platform in reducing side effects and enhancing well-being. Participants are randomly assigned to one of two groups. One group uses the digital platform to report adverse events and receives personalized educational and supportive materials online, while continuing their usual medical treatment. The control group also reports adverse events through the platform but only receives an acknowledgment of their submissions, with no additional personalized content. Throughout approximately one year, participants continue their standard clinical care while researchers collect PROs and monitor outcomes such as progression-free survival and overall survival. The study uses regular assessments to evaluate changes in side effects and quality of life, ensuring ongoing observation of participant experiences and treatment effects.

Digital Support for Multiple Myeloma Quality of Life